KORU Medical Systems, Inc. (KRMD) — Financial statements
Income statement, balance sheet, and cash flow for KORU Medical Systems, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 41↑22.2% | 34↑18.0% | 29↑2.2% | 28↑18.8% | 23 | |
| Cost of Revenue | 16↑26.1% | 12↑4.3% | 12↓5.7% | 13↑28.9% | 10 | |
| Gross Profit | 26↑20.0% | 21↑27.7% | 17↑8.7% | 15↑11.6% | 14 | |
| Operating Expenses | ||||||
| R&D Expenses | 4↓16.6% | 5↓8.4% | 6↑15.9% | 5↑100.4% | 2 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 23 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Expenses | 0.81↓96.4% | 23↑6.0% | 21↑0.2% | 21↑15.7% | 18 | |
| Operating Expenses | 29↑2.9% | 28↑3.0% | 27↑3.2% | 26↑25.7% | 21 | |
| Total Costs & Expenses | 44↑10.0% | 40↑3.4% | 39↑0.3% | 39↑26.7% | 31 | |
| Operating Results | ||||||
| Operating Income | -3↑53.9% | -6↑37.2% | -10↑4.7% | -11↓53.4% | -7 | |
| Depreciation & Amortization | 0.81↑4.9% | 0.77↓11.2% | 0.87↑48.2% | 0.59↑26.8% | 0.46 | |
| EBITDA | -2↑61.9% | -6↑39.6% | -9↑7.8% | -10↓55.2% | -7 | |
| EBIT | -3↑53.9% | -6↑37.2% | -10↑4.7% | -11↓53.4% | -7 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.29↓34.0% | 0.44↓20.8% | 0.56↑285.6% | 0.15↑1012.8% | 0.01 | |
| Interest Income | 0.29↓34.0% | 0.44↓20.8% | 0.56↑285.6% | 0.15↑1012.8% | 0.01 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.36↓6.8% | 0.38↓22.9% | 0.50↑369.6% | 0.11↓84.1% | 0.67 | |
| Income Before Tax | -3↑56.9% | -6↑38.0% | -10↑8.4% | -11↓67.7% | -6 | |
| Income Tax Expense | 0.02↑656.7% | 0.00↓99.9% | 4↑297.0% | -2↓11.8% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -3↑56.5% | -6↑55.9% | -14↓58.7% | -9↓89.8% | -5 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -3↑56.5% | -6↑55.9% | -14↓58.7% | -9↓89.8% | -5 | |
| Bottom-Line Net Income | -3↑56.5% | -6↑55.9% | -14↓58.7% | -9↓89.8% | -5 | |
| EPS (Basic) | -0.06↑56.1% | -0.13↑56.7% | -0.30↓57.9% | -0.19↓90.0% | -0.10 | |
| EPS (Diluted) | -0.06↑56.1% | -0.13↑56.7% | -0.30↓57.9% | -0.19↓90.0% | -0.10 | |
| Weighted Average Shares | 46↑0.8% | 46↑0.4% | 46↑1.3% | 45↑1.4% | 44 | |
| Weighted Average Diluted Shares | 46↑0.8% | 46↑0.4% | 46↑1.3% | 45↑1.4% | 44 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.